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Abstract 
Cancer is one of the most common diseases worldwide, posing 
a serious threat to human health and leading to the deaths of a 
large number of people. It was observed during the drug 
administration in chemotherapy that immune cells, cancer 
cells and normal cells are killed or at least seriously injured 
and also in order to keep dosage of the drug at specific level in 
body, drug should be delivered in specific time and dosage. 
Therefore, to address these problems, a decision-making 
process is needed to identify the most appropriate treatment 
for cancer cases which causes killing of cancer cells by 
considering the number of healthy cells that would be killed. 
Despite the latest technological developments, the current 
methods need to be improved to suggest the most optimized a 
dose of the drug for tumor cells discretely. In this paper we 
proposed mathematical models for tumor, safe and infected 
cells and also fat in patient body then by these coupled 
equations we are able to train our model via using Machine 
Learning method. It is expected that our proposed ANFIS 
model be able to suggest the specialists the most optimum dose 
of the drug, which considers all key factors including cancer 
cells, immune and health cells. The results of the simulations 
exhibit the high accuracy of the proposed intelligent controller 
during the treatment in predicting the behavior of all key 
factors and minimize the usage dose of the drug with regard 
this significant point that the proposed controller gives discrete 
data for treatment which can fill the gap between engineering 
and medical science. Conclusion is that, using of Machine 
Learning method could help us to find the shortest period of 
treatment for each patient and also monitoring the other 
important factors during the treatment.       
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1. Introduction 
Despite a huge research carried out in this domain, the 
prediction and treatment of cancer is very difficult, and in 
some cases impossible. In fact, a wide variety of factors play 
a key role in predicting and treating cancer, and more 
importantly, they have different effects on each other. 
Colorectal cancer incidence rates in men and women are 
37.8% and 27.8%, respectively. It should be noted that cancer 
mortality in men and women is 12.4% and 8.8%, respectively 
[1]. 
This current complexity and above all the static make it 
necessary to understand changes in the dynamics of all-
important and effective cancer states. To eliminate, reduce, or 
at least stabilize the number of tumor cells, the best controllers 
should be developed and used [2]. 
Over the last two decades, various control methods have been 
used to target various cancers. Florian et al. [3] studied a 
nonlinear model predictive control algorithm for breast cancer 
treatment. For example, an adaptive robust control strategy is 
developed for the manipulation of drug usage and 
consequently the tumor volume in cancer chemotherapy by 
Moradi et al. [4]. Yazdanpanah Goharrizi et al. [5] studied a 
self-tuning adaptive controller for 3-D image-guided 
ultrasound cancer therapy. 
Optimal controllers have been widely used to simultaneously 
control tumor and the amount of drug usage [6]. An overview 
of the way optimal control theory interacts with cancer 
chemotherapy was presented by Swan [7]. a schematic 
demonstration was brought forward by Moradi et al. [8]. In 
their study, optimal robust controller for drug delivery in 
cancer chemotherapy was sought and the performance of three 
control approaches was compared. In the other work, Batmani 
and Khaloozadeh [9]worked on optimal chemotherapy for 
cancer treatment, they used SDRE in order to eradicate tumor. 
The main drawback of the optimal control devices is their 
inability to predict the required drug when the uncertainties are 
high [10].  
One way to overcome this disadvantage is through integrated 
controls, including optimal and fuzzy methods. Fuzzy logic 
has been used to help researchers find effective treatments for 
cancer. Al-Daoud [11] studied cancer diagnosis using a 
modified fuzzy network. Evaluation of breast cancer risk using 
fuzzy logic has been reported by Balanica et al. [12]. In 
another similar research El Hamidi et al. [13] worked on an 
evolutionary Neuro-Fuzzy approach toward diagnosis of 
breast cancer. 
In this paper, an ANFIS (adapted neuro-fuzzy inference 
system) [14] controller is presented to treat the cancer. This 
controller can work with unstructured uncertainty. The other 
great ability of this controller is that it allows us to provide 
treatment schedule with discrete data, which represents a 
significant improvement in biomechanics, as this ability can 
connect engineers directly to specialists. The other advantage 
of this important ability follows the role of all states in the 
mathematical models. In addition, this model offers specialists 
to discreetly check the other important conditions at any point 
during a treatment phase. Most importantly, however, that the 
previously proposed controller needs feedback from all states, 
and here are the biggest differences between specialists and 
engineers in dealing with this problem, but in our system to 
find out what dose of the drug you just use the amount of the 
tumor for the first time, the proposed ANFIS system provides 
all the important data needed for the discrete treatment of 
cancer. 
 
The rest of this paper is organized as follows. Sec. 2 presents 
the stablished mathematical model of cancer. The structure of 
PID optimal controller is described in Sec. 3. The proposed 
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ANFIS structure is given completely in Sec. 4. The structure 
of the ANFIS controller and the ANFIS observer is described 
in the sec. 4.2. In Sec. 5, the simulation results are 
demonstrated and compared with those obtained from a 
previous method. The completion of this work is expressed in 
Sec. 6. 
 
 
 
2.  Mathematical Model of HBV 
There are many approaches in order to find the mathematical 
model for tumor cell treatment. Shabel and et al. [15] did the 
first step in this way and consider cancer cell killing rate of a 
drug is proportional to the tumor population. Norton and 
Simon [16] could not explain clinical results in some cases, 
and they found out the cell killing rate is dependent on tumor 
growth rate. In 2012, d’Onforio and et al. [17] showed that the 
Norton and Simon’s model can produce appropriate results in 
comparison with experimental observations. 
In this paper, the basic model presented by [18, 19] is 
considered, this model contains five states, immune cells (I), 
tumor cells (T), normal cells (N), obesity (F) and 
chemotherapy effect (M). The nonlinear system of differential 
equation is presented here 
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All parameters, their symbols and default values used in our 
purposed model are presented in table (2) 
 
Table 1 Parameters value 
Parameters Value 
                                          0.2 
 1 
 0.1 
 0.3 
 1 
 1 
 1 
 1 
 0.5 
 1 
 1 
 1 
 0.2 
 1 
 1.5 
 1 
 1 
 0.33 
 0.01 
 0.3 
  
3. Optimal PID Controller 
The amount of necessitate drug by using PID controller can be 
computed as: 𝑢 = 𝑘$𝑇 + 𝐾( )𝑇 6 
 
Optimizing the control gains ( , ) of equation (6) so as to 
minimize our cost function: 𝐽 = )|𝑢|𝑑𝑡 7 
 
An appropriate cost function is defined such that the amount 
of required drug is minimized while the tumor volume is 
reduced. 
In order to guarantees the smooth behavior of drug some 
constraints are considered. 
 
4. Adaptive network-based fuzzy inference system 
 
4.1Fuzzy 
The combination of the neuronal network and fuzzy with 
allowing for neuro-fuzzy control. As the ANFIS design 
begins, the least squares gradient decay is used for the training. 
Sample data from our optimal PID controller is used to train 
the ANFIS controller. Each learning level is divided into two 
parts. In the forward stage, optimal coefficients are provided 
using the inputs and outputs of each layer. In the reverse phase, 
the parameters of the ANFIS system are then updated. The 
goal is determined based on the ideal response of the system 
under step input. ANFIS only supports Sugeno [20] systems. 
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Fig 1. ANFIS Structure 
Layer 1: degree of membership of the input is computed 
Layer 2: the incoming signals are multiplied. 
Layer 3: output of layer 2 is normalized.  
Layer 4: output function and output of layer 3 are multiplied.  
Layers 5: summation of all outputs in layer 4. 
 
 
 
  
  
 
4.2.1 ANFIS controller 
In this paper, the aim of training the ANFIS controller is to 
discreetly predict the dose of the drug whenever the specialists 
deem necessary, by measuring the amount or volume of the 
tumor cells alone on the first day of treatment. To fulfill this 
purpose, an optimal PID regulator has been designed by 
regular input variables, including immune cells, tumor cells, 
normal cells, obesity factor and chemotherapy. As a result, this 
system will deliver a dose of drugs appropriately with tumor 
cells during the treatment period. 
Our practical ANFIS controller is able to show the specialist 
the amount or volume of tumor cells and the correct dose of 
the drug during treatment at each stage of the treatment they 
need. More importantly, it can help them to predict the 
behavior of the tumor cells under different conditions (with the 
different dose of the drug), this capability makes specialists 
able to treat each patient in terms of his or her drug reactions.
 
. 
 
 
Figure 2 ANFIS Control Diagram 
4.2.2 ANFIS observer 
In this work, an ANFIS observer is designed to estimate the 
other necessary states of the basic dynamic system. Since the 
behavior of immune cells, as we see in equation (1), depends 
on the tumor to train ANFIS observers to estimate safe cells, 
the tumor is considered to be an input variable and the output 
variables are immune cells. These results give specialists 
ability to predict the behavior of the immune system during 
treatment. 
 
Figure 3 ANFIS Observer to estimate safe cells 
Obviously to observe the number of normal cells by 
considering equation (3) Tumor should be consider as an input 
variable. 
 
Figure 4 ANFIS Observer to estimate infected cells 
To train these ANFIS observers several different patients 
were considered.  
 
5. Results 
This section examined the capabilities of the ANFIS controller 
and the observer in two different patients and compared the 
discrete results of ANFIS controllers and observers with the 
optimal continuous controller. Initial conditions are shown in 
Table 2. 
 
Table 2 Initial conditions 
parameters Value 
I (0) 0.15 
                    T (0) 0.2 
N (0) 1 
F (0) 0.25 
M (0) 0.25 
 
 
5.1ANFIS Controller result 
This figure shows the ability of our ANFIS controller to 
estimate the amount or volume of Tumor just by measurement 
on the first day. 
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Figure 5 Comparison the discrete amount or volume of Tumor by ANFIS 
controller with real data 
 
The high ability of discrete ANFIS controller, designed and 
trained to predict the optimal amount of drug was shown by 
comparison with the result of optimal continuous controller. 
 
 
 
  
Figure 6 Comparison the amount of discrete drug for patient by ANFIS 
controller with continuous amount of drug by optimal controller 
 
 
The discrete results of the ANFIS controller are very similar 
to the continuous results of the optimal controller, although the 
ANFIS controller only needs to know the amount or volume 
of the tumor on the first day of treatment. 
 
The next graph contained the amount of drug in these two 
controls, but this time for another patient. 
 
Figure 7 Comparison the amount of discrete drug for patient by ANFIS 
controller with continuous amount of drug by optimal controller for new 
patient 
This kind of discrete and roughly estimated amount of the drug 
can be really helpful for specialists to predict the situation they 
can meet for each patient under different conditions. 
 
The key point is that the ANFIS controller is not a model base 
and can work with experimental data. 
 
 
 
 
 
 
 
 
 
 
5.2ANFIS observer results 
5.2.1Monitoring immune cells 
In this figure, the trend immune cells were compared with 
experimental data during treatment with ANFIS observer.  
 
Figure 8 Comparison the amount of discrete number of immune cells for 
patient by ANFIS controller with continuous amount of drug by optimal 
controller 
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Figure 9 Comparison the amount of discrete number of immune cells for 
patient by ANFIS controller with continuous amount of drug by optimal 
controller for new patient 
Although error can be seen in the early days, results show that 
ANFIS observer can accurately estimate behavior of immune 
cells during treatment for new patients in the course of time. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5.2.2Monitoring safe cells 
In figure 10, the trend normal cells during the treatment with 
ANFIS observer was compared to experimental data. 
 
 
Figure 10 Comparison the amount of discrete number of immune cells for 
patient by ANFIS controller with continuous amount of drug by optimal 
controller 
 
 
The comparison was repeated for new patient. 
 
Figure 11 Comparison the amount of discrete number of immune cells for 
patient by ANFIS controller with continuous amount of drug by optimal 
controller for new patient 
The high ability of ANFIS observer leads to the monitoring of 
the other necessary state of control system in each treatment 
section. 
 
 
6. Conclusion 
In this study, an ANFIS (adaptive neuro-fuzzy inference 
system) controller for treating cancer was presented, and an 
ANFIS observer rendered to estimate the necessary system 
conditions. The ANFIS controller only needs the amount or 
volume of tumor cells as input variables to discretely estimate 
the amount of drug needed in order to eliminate tumor by 
minimizing the number of healthy cells which would be killed 
during the treatment. This controller can provide treatment 
schedule similar to what specialists do in the clinical 
environment, which of course is followed by a strong link 
between medical and engineering sciences. This goal was 
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achieved by using real patient data to directly train ANFIS 
controllers. However, in previous models, all necessary states 
including healthy and immune cells should be known to 
estimate dose of the drug. 
In simulations, the amount of tumor cells in a patient was 
measured in the first day of treatment, and then the ANFIS 
system separately reported information about the amount or 
volume of the tumor and the appropriate dose of the drug 
during the treatment period for each specific patient. The 
performance of the ANFIS controller was compared with the 
optimal PID controller and the performance of the ANFIS 
observer compared to the experimental data. The accuracy of 
our results shows that our proposed method can be used in 
realistic clinical treatments that help optimize the dose of the 
drug injected per day or week and consequently decrease the 
treatment period and healthy cells kill rate. 
 
References 
 
[1]  R. L. Siegel and e. al, "Colorectal Cancer 
Statistics," A Cancer Journal for Clinicians, 
vol. 67, no. 3, pp. 177-193, 2017.  
[2]  S Abtahi, M Sharifi "Machine Learning 
Method to Control and Observe for 
Treatment and Monitoring of Hepatitis B 
Virus" arXiv preprint arXiv:2004.09751, 2020. 
[3]  J. A. Florian, J. L. Eiseman and R. S. Parker, 
"A nonlinear model predictive control 
algorithm for breast cancer treatment," IFAC 
Proceeding Volumes, vol. 37, no. 9, pp. 929-
940, 2004.  
[4]  Hamed Moradi, Mojtaba Sharifi and 
Gholamreza Vossoughi, "Adaptive robust 
conrol of cancer cheomotherapy in the 
presence of parametric uncertainties: A 
comparison between three hypotheses," 
Computers in Biology and Medicine, vol. 56, 
pp. 145-157, 2015.  
[5]  A. Yazdanpanah Goharrizi, R. H. Kwong and 
R. Chopra, "A self-tuning adaptive controller 
for 3-D image-guided ultrasound cancer 
therapy," IEEE Transactions on Biomedical 
Engineering, vol. 61, no. 3, pp. 911-919, 
2014.  
[6]  J. J. Cunningham, J. S. Brown, R. A. 
Gatenby and K. Staňková, "Optimal control 
to develop therapeutic strategies for 
metastatic castrate resistant prostate cancer," 
Journal of Theoretical Biology, vol. 459, pp. 
67-78, 2018.  
[7]  G. W. Swan, "Role of optimal control theory 
in cancer chemotherapy," Mathematical 
Biosciences, vol. 101, no. 2, pp. 237-284, 
1990.  
[8]  H. Moradi, G. R. Vossoughi and H. Salarieh, 
"Optimal robust control of drug delivery in 
cancer chemotherapy: a comparison between 
three control approaches," Computer 
Methods and Programs Biomedicine, vol. 
112, p. 69–83, 2013.  
[9]  Y. Batmani and H. Khaloozadeh, "Optimal 
chemotherapy in cancer treatment: state 
dependent Riccati equation control and 
extended Kalman filter," Optimal Control 
Applications and Methods, vol. 34, no. 5, pp. 
562-577, 2013.  
[10]  Y. Batmani and H. Khaloozadeh, "Optimal 
chemotherapy in cancer treatment: state 
dependent Riccati equation control and 
extended Kalman filter," Optimal Control 
Applications and Methods, vol. 34, no. 5, pp. 
562-577, 2012.  
[11]  E. Al-Daoud, "Cancer diagnosis using 
modified Fuzzy network," Universal Journal 
of Computer Science and Engineering 
Technology, vol. 1, no. 2, pp. 73-78, 2010.  
[12]  V. Balanica and e. al, "Evaluation of breast 
cancer risk by using Fuzzy logic," U.P.B. Sci. 
Bull., Series C, vol. 73, no. 1, 2011.  
[13]  R. El Hamidi, M. Njah and M. Chtourou, 
"An evolutionary neuro-fuzzy approach to 
breast cancer," in Systems Man and 
Cybernetics (SMC), 2010 IEEE International 
Conference on, Istanbul, 2010.  
[14]  J.-S. R. Jang, "ANFIS: adaptive-network-
based fuzzy inference system," ieee 
transaction on systems, vol. 23, 1993.  
[15]  F. Schabel Jr., H. Skipper and W. Wilcox, 
"Experimental evaluation of potential 
anticancer agents. XIII. On the criteria and 
kinetics associated with curability of 
experimental leukemia," Cancer 
Chemotherapy Report, vol. 25, pp. 1-111, 
1964.  
[16]  L. Norton and R. Simon, "Tumor size, 
sensitivity to therapy, and design of treatment 
schedules," Cancer Treatment Reports, vol. 
61, pp. 1307-1317, 1977.  
[17]  A. d’Onofrio, A. Gandolfi and S. Gattoni, 
"The Norton–Simon hypothesis and the onset 
7 
 
of non-genetic resistance to chemotherapy 
induced by stochastic fluctuations," Journal 
of Physica A, vol. 391, p. 6484–6496, 2012.  
[18]  N. Babaei and M. U. Salamci, "Personalized 
drug administration for cancer treatment 
using model refrence adaptive control," 
Journal of Theoretical Biology, vol. 371, pp. 
24-44, 2015.  
[19]  R. Ku-Carrilo, S. E. Delgadillo and Chen-
Charpentier, "A mathematical model for the 
effect of obesity on cancer growth and on the 
immune system response," Applied 
Mathematical Modeling, vol. 40, no. 7-8, pp. 
4908-4920, 2016.  
[20]  Michio SUGENO and Tomohiro TAKAGI, 
"Fuzzy identification of systems and its 
applications to modeling and control," fuzzy 
sets and systems, vol. 15, pp. 116-132, 1985.  
 
 
 
